- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02021916
Louisville Cooperative Tissue Biorepository (LCTB)
November 9, 2021 updated by: Robert C. Martin, University of Louisville
Louisville Cooperative Tissue Biorepository of the James Graham Brown Cancer Center Tissue Collection Consent
To provide appropriate collection, storage, and distribution of specimens and medical data to local investigators who have approved IRB protocols for their specific research purposes.
Study Overview
Status
Completed
Conditions
Detailed Description
The mission of the Louisville Cooperative Tissue Biorepository is to appropriately collect normal and abnormal tissues that are removed from the human body as a part of standard medical and surgical practice after adequate portions are secured by surgical pathologists to allow for correct diagnoses to be made.
The LCTB securely stores appropriately collected human samples for research purposes and appropriately allocates these samples to local investigators for research purposes.
The LCTB team appropriately documents all points in the process of obtaining informed consent, collection, storage, and allocation of tissues.
Study Type
Observational
Enrollment (Actual)
17499
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Kentucky
-
Louisville, Kentucky, United States, 40202
- University of Louisville
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
7 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Patients undergoing surgery for removal of normal or abnormal tissues that are removed from the human body as part of standard medical and surgical practice at the University of Louisville Hospital, Norton Hospital downtown, Jewish Hospital downtown and Kosair Children's Hospital.
Description
Inclusion Criteria:
- Patients undergoing surgery for removal or normal and abnormal tissues as part of standard medical and surgical practice
Exclusion Criteria:
- Patients with known systematic infections including septic patients with bacterial and viral infections, hepatitis, HIV, TB and other defined pathogens will not be included.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Collect normal and abnormal tissues that are removed from the human body as a part of standard surgical practice after adequate portions are secured by surgical pathologists to allow for correct diagnoses to be made.
Time Frame: 15 Years
|
15 Years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2005
Primary Completion (Actual)
January 11, 2018
Study Completion (Actual)
January 11, 2018
Study Registration Dates
First Submitted
December 20, 2013
First Submitted That Met QC Criteria
December 20, 2013
First Posted (Estimate)
December 27, 2013
Study Record Updates
Last Update Posted (Actual)
November 10, 2021
Last Update Submitted That Met QC Criteria
November 9, 2021
Last Verified
November 1, 2021
More Information
Terms related to this study
Other Study ID Numbers
- 397.05
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Normal and Abnormal Tissue
-
Heidelberg Engineering GmbHRecruitingEyes With Normal Anterior Segment | Eyes With Abnormal Anterior SegmentUnited States
-
Delphinus Medical Technologies, Inc.University of Chicago; Boston Biomedical AssociatesCompletedBreast Cancer Detection | Dense Breast Parenchyma | Benign Breast Findings | Normal Breast Screening | Abnormal Breast ScreeningUnited States
-
Delphinus Medical Technologies, Inc.University of Chicago; Boston Biomedical Associates; Reed Technical Associates...CompletedBreast Cancer Detection | Dense Breast Parenchyma | Benign Breast Findings | Normal Breast Screening | Abnormal Breast ScreeningUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)National Institute of Mental Health (NIMH)RecruitingNormal and Abnormal Cardiovascular PhysiologyUnited States
-
Case Comprehensive Cancer CenterCompletedAbnormal Breast TissueUnited States
-
University of MichiganTerminatedOther Abnormal Granulation Tissue NosUnited States
-
Instituto Ecuatoriano de Enfermedades DigestivasCompleted
-
St. Jude Children's Research HospitalRecruitingNormal and Diseased Tissue and Body Fluids SamplesUnited States
-
National Institute of Allergy and Infectious Diseases...TerminatedHealthy Volunteers | Abnormal Phagocyte FunctionUnited States
-
National Cancer Institute (NCI)CompletedMenopause | Normal PhysiologyMongolia